Enanta Pharmaceuticals Inc（ENTA）價格預測ENTAEnanta Pharmaceuticals Inc

Alphio's ENTA stock price prediction model matches the current Enanta Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.05 (+0.43%). The 1-week path is $11.90 (-0.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Enanta Pharmaceuticals is currently trading at $11.64, with a forward P/E ratio of 44.05, indicating that the stock may be overvalued based on future earnings expectations. The RSI is at 49.01, suggesting that the stock is neither overbought nor oversold, which means it may not be the best time to buy. The recent insider buying trend has increased by 137.44%, indicating some confidence from insiders, but the overall financial performance shows significant losses, with a net income loss of $19.5 million in the latest quarter. The main risk is the high forward P/E ratio, which suggests that the stock price may not be justified by future earnings potential, making it a hold for now.

Enanta Pharmaceuticals Inc (ENTA) last closed at $12, gaining +3.09%. These facts feed the 1-day and 1-week ENTA price prediction above.